Evidence map›Paper›PMID 34811589›Full record

ReviewHuman genetics2022

Evaluation of copy number variants for genetic hearing loss: a review of current approaches and recent findings.

Wafaa Abbasi, Courtney E French, Shira Rockowitz, Margaret A Kenna, A Eliot Shearer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wafaa AbbasiBoston University School of Medicine, Boston, MA, USA.
Courtney E FrenchBoston Children's Hospital, Children's Rare Disease Cohort Initiative, Boston, MA, USA.
Shira RockowitzBoston Children's Hospital, Children's Rare Disease Cohort Initiative, Boston, MA, USA.
Margaret A KennaBoston Children's Hospital, Children's Rare Disease Cohort Initiative, Boston, MA, USA.
A Eliot ShearerBoston Children's Hospital, Children's Rare Disease Cohort Initiative, Boston, MA, USA. eliot.shearer@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-5324-4805
Boston Children's Hospital · USBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural variation includes a change in copy number, orientation, or location of a part of the genome. Copy number variants (CNVs) are a common cause of genetic hearing loss, comprising nearly 20% of diagnosed cases. While large deletions involving the gene STRC are the most common pathogenic CNVs, a significant proportion of known hearing loss genes also contain pathogenic CNVs. In this review, we provide an overview of currently used methods for detection of CNVs in genes known to cause hearing loss including molecular techniques such as multiplex ligation probe amplification (MLPA) and digital droplet polymerase chain reaction (ddPCR), array-CGH and single-nucleotide polymorphism (SNP) arrays, as well as techniques for detection of CNVs using next-generation sequencing data analysis including targeted gene panel, exome, and genome sequencing data. In addition, in this review, we compile published data on pathogenic hearing loss CNVs to provide an up-to-date overview. We show that CNVs have been identified in 29 different non-syndromic hearing loss genes. An understanding of the contribution of CNVs to genetic hearing loss is critical to the current diagnosis of hearing loss and is crucial for future gene therapies. Thus, evaluation for CNVs is required in any modern pipeline for genetic diagnosis of hearing loss.

Indexed as

DeafnessHearing LossDNA Copy Number VariationsExomeHigh-Throughput Nucleotide SequencingHumansIntercellular Signaling Peptides and ProteinsIntercellular Signaling Peptides and ProteinsSTRC protein, human

Identifiers

PMID34811589
OpenAlexW3216342019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.